Stay updated on Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    2 days ago
    No Change Detected
  3. Check
    3 days ago
    No Change Detected
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    7 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study completion date for the clinical trial evaluating the efficacy and safety of regorafenib in patients with advanced liver cancer who had progressed after sorafenib treatment.
    Difference
    0.1%
    Check dated 2024-06-06T16:01:58.000Z thumbnail image
  7. Check
    23 days ago
    Change Detected
    Summary
    The value 'Participation Criteria Collaborators - No information provided' has been updated to 'Participation Criteria Researchers look for people who fit a certain description, called eligibility criteria.' This change indicates a shift towards providing detailed information about the criteria researchers are seeking in potential study participants.
    Difference
    26%
    Check dated 2024-05-22T07:32:58.000Z thumbnail image
  8. Check
    44 days ago
    Change Detected
    Difference
    0.8%
    Check dated 2024-04-30T22:26:24.000Z thumbnail image

Stay in the know with updates to Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Regorafenib after Sorafenib for Hepatocellular Carcinoma Clinical Trial page.